THC Therapeutics board removes director Brandon Romanek; Romanek disputes removal as invalid

THC Therapeutics, Inc.

On April 2, 2025, majority shareholder voted to remove Brandon Romanek from board; remaining board removed him from all positions.
Company requested Romanek's response; he provided a letter after the original 8-K was filed, now included as Exhibit 99.1.
Romanek's letter states termination is invalid because proper procedure per THC Therapeutics bylaws was not followed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brandon Romanek

Director

THC Therapeutics, Inc.

Effective: 2025-04-02
Filed: April 17, 2025, 7:59 PM ET

On April 2, 2025, the majority shareholder of the THC Therapeutics, Inc. (the "Company"), voted to remove Brandon Romanek from the Board of Directors of the Company. Further, on that same day, the remaining Board of Directors removed Mr. Romanek from any and all positions held at the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brandon Romanek was removed as Director at THC Therapeutics, Inc..

Action: removed
Role: Director

Exact text from the filing

On April 2, 2025, the majority shareholder of the THC Therapeutics, Inc. (the "Company"), voted to remove Brandon Romanek from the Board of Directors of the Company. Further, on that same day, the remaining Board of Directors removed Mr. Romanek from any and all positions held at the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0001477932-25-002821

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.